Physician

Neal Shore, DR

According to 2025 Medicare claims, Neal Shore, DR (NPI: 1265423453) practices urology in the Myrtle Beach-Conway-North Myrtle Beach, SC market, with the plurality of this provider's patient population coming from Horry, SC. This provider's primary affiliated billing organization is AUC UROLOGISTS LLC (NPI: 1780454017; TIN: 93-4364404) and primary practice location at 29572-4607. Shore is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Shore's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 962 traditional Medicare patients, billed 27,418 HCPCS/CPT codes, and received $980,113 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,827 prescription claims across 378 beneficiaries totaling $6,939,767 in drug costs, led by Xtandi (Enzalutamide). DME data shows 49 claims. Open Payments data shows 1,018 records totaling $8,454,560. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $700,893 to $6,939,767. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $1,876 to $3,277.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$705K$1.4M2015 Medicare payment: $1,091,060 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,061,666 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,326,767 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,137,748 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,410,391 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,312,098 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $934,393 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $849,868 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $863,732 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $980,113 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,40752,442$1,091,060
20161,51358,639$1,061,666
20171,45768,528$1,326,767
20181,65049,701$1,137,748
20191,69047,792$1,410,391
20201,55852,796$1,312,098
20211,37742,248$934,393
20221,27132,543$849,868
20231,10230,375$863,732
202496227,418$980,113

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.5M$7.0M2015 Drug cost: $700,893 (USD; Tot_Drug_Cst)2016 Drug cost: $692,092 (USD; Tot_Drug_Cst)2017 Drug cost: $768,532 (USD; Tot_Drug_Cst)2018 Drug cost: $1,175,001 (USD; Tot_Drug_Cst)2019 Drug cost: $1,926,406 (USD; Tot_Drug_Cst)2020 Drug cost: $2,783,957 (USD; Tot_Drug_Cst)2021 Drug cost: $3,949,793 (USD; Tot_Drug_Cst)2022 Drug cost: $5,718,273 (USD; Tot_Drug_Cst)2023 Drug cost: $6,958,067 (USD; Tot_Drug_Cst)2024 Drug cost: $6,939,767 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154221,406$700,893
20164481,575$692,092
20174731,762$768,532
20185261,701$1,175,001
20196172,448$1,926,406
20206032,453$2,783,957
20215532,325$3,949,793
20224602,110$5,718,273
20233791,822$6,958,067
20243781,827$6,939,767

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$32K$65K2015 Medicare payment: $22,864 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $24,533 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $18,470 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $27,309 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $64,823 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $56,797 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $42,341 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $12,052 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $9,178 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $9,279 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201537228$22,864
201635244$24,533
201718148$18,470
201825138$27,309
201929153$64,823
202018130$56,797
202113124$42,341
2022N/R55$12,052
2023N/R40$9,178
2024N/R49$9,279

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more357777$97
84153Psa (prostate specific antigen) measurement, total370686$18
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's5011,271$13
36415Insertion of needle into vein for collection of blood sample440584$9
81001Manual urinalysis test with examination using microscope, automated5481,080$3

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XtandiEnzalutamide1534,590$2,119,690
NubeqaDarolutamide1514,530$1,976,459
ErleadaApalutamide571,770$858,896
OrgovyxRelugolix2497,674$661,194
TalzennaTalazoparib Tosylate29870$355,960

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4351Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), eachNN/R25$8,723
A4356External urethral clamp or compression device (not to be used for catheter clamp), eachNN/R12$499
A4332Lubricant, individual sterile packet, eachNN/R12$56

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.266$448,602Janssen Research & Development, LLC
Research PaymentsReported research-related payment or transfer-of-value amount.750$8,005,958PFIZER INC.
Ownership / Investment InterestsReported value of ownership or investment interests.2$4,471,851SN Holdings, LLC

FAQ

What Medicare data is available for Neal Shore, DR?

Tedicare shows public-source Medicare data for Neal Shore, DR (NPI 1265423453), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Neal Shore, DR have ACO affiliation data?

Neal Shore, DR is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Neal Shore, DR?

Neal Shore, DR is linked to AUC UROLOGISTS LLC (billing NPI 1780454017) in the available physician profile data.

Does Neal Shore, DR have Open Payments data?

Neal Shore, DR has 1,018 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.